<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fibromuscular <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (FMD) involves small- and medium-sized arteries, being a well-known cause of <z:hpo ids='HP_0000822'>hypertension</z:hpo> in young Caucasian women, when renal arteries are involved </plain></SENT>
<SENT sid="1" pm="."><plain>The etiology of FMD remains unknown, despite many theories </plain></SENT>
<SENT sid="2" pm="."><plain>A genetic component is suspected to exist, because the pathology affects primarily Caucasians </plain></SENT>
<SENT sid="3" pm="."><plain>Association between FMD and the HLA-DRw6 histocompatibility antigen has also been described </plain></SENT>
<SENT sid="4" pm="."><plain>The major sites affected are renal, cerebral, carotid, visceral, iliac, subclavian, brachial and popliteal arteries </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical manifestations correlate with the affected site, arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> being a frequent symptom, resulting from the involvement of the renal arteries in 60%-75% of the cases </plain></SENT>
<SENT sid="6" pm="."><plain>The diagnosis of FMD is made by histopathology and/or angiography </plain></SENT>
<SENT sid="7" pm="."><plain>FMD can manifest as a systemic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e>, mimicking <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>This understanding is important because <z:hpo ids='HP_0002633'>vasculitis</z:hpo> and FMD can both have a severe clinical course, but require distinct treatments </plain></SENT>
<SENT sid="9" pm="."><plain>The differential diagnosis can be difficult in face of an atypical clinical presentation or lack of histopathologic confirmation </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0003745'>Isolated cases</z:hpo> of FMD have been reported mimicking the following conditions: <z:e sem="disease" ids="C0031036" disease_type="Disease or Syndrome" abbrv="">polyarteritis nodosa</z:e>, <z:e sem="disease" ids="C0013720" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Ehlers-Danlos</z:e>'s <z:e sem="disease" ids="C1567741" disease_type="Disease or Syndrome" abbrv="">syndrome, Alport's</z:e> syndrome, <z:hpo ids='HP_0002666'>pheochromocytoma</z:hpo>, <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e>, and <z:e sem="disease" ids="C0039263" disease_type="Disease or Syndrome" abbrv="">Takayasu</z:e>'s <z:hpo ids='HP_0012089'>arteritis</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Rheumatologists should be aware of this differential diagnosis </plain></SENT>
<SENT sid="12" pm="."><plain>Treatment of FMD is recommended only in symptomatic cases, and consists in revascularization, which may be either surgical or via percutaneous transluminal angioplasty </plain></SENT>
<SENT sid="13" pm="."><plain>In FMD, the effects of corticotherapy can directly and rapidly harm the vascular wall, aggravating the lesions </plain></SENT>
</text></document>